Can Europe afford the next generation of medicines? : vimars

There is a wave of cell and gene therapies in the pipeline, but EU countries will have to deal with hefty price tags.

Related Keywords

China , Lydie Meheus , Tim Hunt , Yannis Natsis , Novarti Kymriah , Matthew Durdy , Novarti Zolgensma , Anticancer Fund , European Medicines Agency , Health Technology Assessment , European Commission , Alliance For Regenerative Medicine , Gene Therapy Catapult , Regenerative Medicine , European Social Insurance Platform , Technology Assessment , Stephen Majors , Blood , Cells And Tissues , Cancer , Clinical Trials , Drug And Device Safety , Eu27 , Genetics , Health Systems , Major And Chronic Diseases , Medicines , Patients , Pharma , Rare Diseases , Regulation , Research , United Kingdom , United States ,